S2CID 40084640
Athletes and bodybuilders use it illegally because of promises of increased muscle mass, improved physical performance, and faster tissue recovery time after injuries
With improved protein synthesis, the patient can lose fat and grow new, healthy tissue
CJC-1295 and Ipamorelin are unapproved research chemicals
The key findings from this clinical program include significant reductions in body weight and fat mass in treatment groups compared to placebo, preferential loss of abdominal and visceral adipose tissue, no changes in serum IGF-1 levels at any dose tested, no negative effects on glucose metabolism or insulin sensitivity, no significant adverse events related to metabolic or endocrine disruption, and safety profile indistinguishable from placebo for most parameters
injection of 160 mg/kg tamoxifen for five consecutive days, as previously described 33 ) to induce Cre recombinase activity and Gclc excision (Fig